Clinical Drug Development

Our team will write the Investigator Brochure and Phase I protocol as part of the IND or other regulatory submission to allow the commencement of first-in-man studies. As part of the integrated development plan we also design cost and time efficient later stage clinical programs that will optimize the ability to reach meaningful clinical objectives and be acceptable to world-wide regulatory authorities.